In-silico design and ADMET predictions of some new imidazo[1,2-a]pyridine-3-carboxamides (IPAs) as anti-tubercular agents

Tuberculosis (TB) is one of the leading infectious diseases worldwide even with the ravaging COVID-19 pandemic in recent times. This mandated further search and exploration of more possible anti-TB drug candidates against M. tuberculosis strains. As an extension of our previous work on the homology...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdullahi, Mustapha, Das, Niloy, Adeniji, Shola Elijah, Usman, Alhassan Kabiru, Sani, Ahmad Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450222/
https://www.ncbi.nlm.nih.gov/pubmed/34568589
http://dx.doi.org/10.1016/j.jctube.2021.100276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450222/
https://www.ncbi.nlm.nih.gov/pubmed/34568589
http://dx.doi.org/10.1016/j.jctube.2021.100276

Ejemplares similares